A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.
Xiaotong Jiang, Marisa McGinley, Joshua Johnston, Jay Alberts, Robert Bermel, Daniel Ontaneda, Robert T Naismith, Robert Hyde, Nick Levitt, Johan van Beek, Zhaonan Sun, Nolan Campbell, Christian Barro
{"title":"A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.","authors":"Xiaotong Jiang, Marisa McGinley, Joshua Johnston, Jay Alberts, Robert Bermel, Daniel Ontaneda, Robert T Naismith, Robert Hyde, Nick Levitt, Johan van Beek, Zhaonan Sun, Nolan Campbell, Christian Barro","doi":"10.1177/13524585241301854","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A digital adaptation of the nine-hole peg test (9HPT) was developed with the potential to provide novel disability features for patients with multiple sclerosis (PwMS).</p><p><strong>Objectives: </strong>The objectives were to evaluate the 9HPT features based on reliability, prognosis, and discrimination between treatment groups.</p><p><strong>Methods: </strong>The MS partners Advancing Technology and Health Solutions (MS PATHS) cohort data were used to derive new features including completion time and speed. Association and reliability between features and clinical outcomes were tested by intraclass correlation coefficients (ICCs) with repeated measures. The added prognostic value of the features for a clinically meaningful decline was assessed by time-to-event analyses with likelihood ratio tests. The estimated effect size between treatment efficacy groups was acquired from linear mixed-effects models. Sample size was calculated for a hypothetical randomized clinical trial.</p><p><strong>Results: </strong>For the 10,843 PwMS, speed and completion time were associated with MS disability. Compared with time, speed showed higher reliability (ICC = 0.78 vs 0.74), added benefits in predicting disability worsening (<i>p</i> < 0.001), better discrimination between high- and low-efficacy groups (effect size: 0.035 vs 0.015), and an 18% reduction in required sample size for a 1-year clinical trial.</p><p><strong>Conclusion: </strong>Integrating horizontal hand distances traveled over the 9HPT pegboard can be a more reliable measure of hand function.</p>","PeriodicalId":18874,"journal":{"name":"Multiple Sclerosis Journal","volume":" ","pages":"81-92"},"PeriodicalIF":4.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13524585241301854","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: A digital adaptation of the nine-hole peg test (9HPT) was developed with the potential to provide novel disability features for patients with multiple sclerosis (PwMS).
Objectives: The objectives were to evaluate the 9HPT features based on reliability, prognosis, and discrimination between treatment groups.
Methods: The MS partners Advancing Technology and Health Solutions (MS PATHS) cohort data were used to derive new features including completion time and speed. Association and reliability between features and clinical outcomes were tested by intraclass correlation coefficients (ICCs) with repeated measures. The added prognostic value of the features for a clinically meaningful decline was assessed by time-to-event analyses with likelihood ratio tests. The estimated effect size between treatment efficacy groups was acquired from linear mixed-effects models. Sample size was calculated for a hypothetical randomized clinical trial.
Results: For the 10,843 PwMS, speed and completion time were associated with MS disability. Compared with time, speed showed higher reliability (ICC = 0.78 vs 0.74), added benefits in predicting disability worsening (p < 0.001), better discrimination between high- and low-efficacy groups (effect size: 0.035 vs 0.015), and an 18% reduction in required sample size for a 1-year clinical trial.
Conclusion: Integrating horizontal hand distances traveled over the 9HPT pegboard can be a more reliable measure of hand function.
背景:一种数字化的九孔钉试验(9HPT)被开发出来,有可能为多发性硬化症(PwMS)患者提供新的残疾特征。目的:目的是基于可靠性、预后和治疗组之间的区别来评估9HPT特征。方法:采用MS合作伙伴先进技术和健康解决方案(MS PATHS)队列数据,得出包括完成时间和速度在内的新特征。通过重复测量的类内相关系数(ICCs)来检验特征与临床结果之间的相关性和可靠性。通过时间-事件分析和似然比检验评估这些特征对临床有意义的衰退的附加预后价值。治疗疗效组之间的估计效应大小通过线性混合效应模型获得。为一个假设的随机临床试验计算样本量。结果:在10,843个PwMS中,速度和完成时间与MS残疾有关。与时间相比,速度显示出更高的可靠性(ICC = 0.78 vs 0.74),在预测残疾恶化方面增加了益处(p < 0.001),在高效组和低效组之间有更好的区分(效应量:0.035 vs 0.015),并且在1年临床试验中所需的样本量减少了18%。结论:综合手在9HPT钉板上移动的水平距离可以更可靠地测量手的功能。
期刊介绍:
Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.
The journal for your research in the following areas:
* __Biologic basis:__ pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics
* __Epidemology and genetics:__ genetics epigenetics, epidemiology
* __Clinical and Neuroimaging:__ clinical neurology, biomarkers, neuroimaging and clinical outcome measures
* __Therapeutics and rehabilitation:__ therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management
Print ISSN: 1352-4585